Engineering the Full Spectrum of Human Milk Oligosaccharides at Global Scale
- Examine how plant-based bioengineering unlocks the production of structurally complex and high-value HMOs that have been difficult or impossible to manufacture using microbial fermentation platforms
- Explore scalable pathways for producing a broad diversity of HMOs at lower cost, leveraging agricultural systems to improve yield, consistency, and economic viability for widespread infant formula adoption
- Discuss how access to the full spectrum of HMOs can better support infant gut microbiome development and immune health, enabling formula designs that more closely reflect the functional complexity of human milk
- Assess the scientific, manufacturing, and investment considerations for translating plant-derived HMO platforms from research breakthroughs into commercially viable, globally accessible nutrition solutions for infants and beyond